// App-Quantinova.ai

: Effect of tralokinumab on GINA control in severe, uncontrolled asthma

Researchers

Presenter

  • Christopher E. Brightling

Principal Investigators

  • Edward Piper

  • Peter Wessman

  • Gene Colice

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

Locations

  • United Kingdom

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • CAT-354

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT01402986

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved